eAbstract: Efficacy and Safety of Azithromycin 1.5% Eye Drops for Purulent Bacterial Conjunctivitis in Pediatric Patients

Article

The results of this study found that azithromycin 1.5% eye drops are more effective than tobramycin for treating bacterial conjunctivitis.

Click here to access this third-party resource:

Efficacy and Safety of Azithromycin 1.5% Eye Drops for Purulent Bacterial Conjunctivitis in Pediatric Patients

Journal: The Pediatric Infectious Disease Journal (March 2010)

Authors: Bremond-Gignac D, Mariani-Kurkdjian P, Beresniak A, et al.

Purpose: To evaluate the safety and efficacy of azithromycin 1.5% eye drops for the treatment of purulent bacterial conjunctivitis in children.

Results: Compared to tobramycin 0.3%, with 1 drop every 2 hours for 2 days and then 4 times daily for 5 days, azithromycin 1.5% eye drops twice daily for 3 days “provided a greater bacteriologic cure on day 3 than did tobramycin (P < 0.001) and eradicated bacteria that were defined as resistant, using classical antibiogram.” The authors conclude: “azithromycin 1.5% eye drops leads to a rapid clinical and microbiological cure.”

Related Videos
Discussing Post-Hoc Data on Ruxolitinib for Nonsegmental Vitiligo, with David Rosmarin, MD
A panel of 3 experts on dry eye
1 KOL is featured in this series.
1 KOL is featured in this series.
Shawn Kwatra, MD, an expert on atopic dermatitis
Shawn Kwatra, MD, an expert on atopic dermatitis
Ruth Ann Vleugels, MD, MPH, MBA, an expert on atopic dermatitis
Ruth Ann Vleugels, MD, MPH, MBA, an expert on atopic dermatitis
Brendon Neuen, MBBS, PhD | Credit: X.com
Sorana Segal-Maurer, MD, an expert on HIV
© 2024 MJH Life Sciences

All rights reserved.